gastroenterologist-2016_scientifictracks-abstracts

22 / 50

Notes:
Page 37
Gastro 2016
August 11-12, 2016
Volume 6, Issue 4(Suppl) J Gastrointest Dig Syst 2016
ISSN:2161-069X JGDS, an open access journal
conferenceseries .com
August 11-12, 2016 Birmingham, UK
6th Global Gastroenterologists Meeting
Monir H Bahgat et al., J Gastrointest Dig Syst 2016, 6:4(Suppl)
Albumin infusion in chronic liver disease: The current challenges
Monir H Bahgat and Shahira El Etreby
Mansoura University, Egypt
The human body contains 4-5 g/kg of albumin. This amount is largely distributed in the extracellular space; with a plasma
concentration of 4-5 g/dl. It is responsible for almost 80%of the osmotic pressure of the plasma.Therefore, Human Albumin
Solution (HAS) has been used as a physiological plasma expander. However, its limited availability and high cost make it
essential to define recommendations for its appropriate use. Numerous studies have been done on the uses of HAS, which
sometimes reached inconsistent conclusions. However, most of the appropriate uses of HAS are related to the management
of complications of Chronic Liver Disease (CLD), including ascites, spontaneous bacterial peritonitis, and hepatorenal
syndrome. So, all the current recommendations and challenges encountered during the use of HAS in the management of
complicated CLD will be reviewed, including the appropriate indications, different dosing regimens, possible complications,
and alternatives. In addition, occasionally appropriate, inappropriate or controversial uses of HAS will also be reviewed.
Biography
Monir H Bahgat has done his specialization in Internal Medicine in the year 1995. Currently, he is a Professor of Hepatology and Gastroenterology (Internal
Medicine department), Manoura University Egypt. He is a member of EASL and IASL.